The """"""""Amyloid Cascade Hypothesis"""""""" positing amyloid-ft (Aft) as a fundamental driving mechanism in disease pathogenesis is supported by numerous cellular, animal and human studies. However, an """"""""Alternate Amyloid Hypothesis"""""""", positing Aft as an antioxidant that occurs secondary to oxidative stress, is an equally valid explanation for the wealth of in vitro and in vivo findings related to Aft. That the """"""""Alternate Amyloid Hypothesis"""""""" and the """"""""Amyloid Cascade Hypothesis"""""""" are essentially unchallenged by any currently available data is troubling from a scientific perspective and more so from a clinical perspective where current therapeutic efforts are targeted at the removal or limiting of Aft from the brain. The goal of our proposal is to conduct a series of experiments that should critically test both hypotheses to determine the role of Aft as pathogen or protectant. Specifically, we propose to use inducible transfected cell cultures together with state of the art molecular techniques to test the predominant hypothesis in the field.
Our Specific Aims, guided by novel preliminary data are as follows:
Aim 1) Determine whether pharmacologic inhibition of Aft with BACE inhibitors affects susceptibility to oxidative stress and whether this effect can be reversed (""""""""rescued"""""""") by transfection with Aft1-40, Aft1-42, or C99;
Aim 2) Determine whether mutations associated with familial Alzheimer disease are associated with alterations in oxidative stress and whether alterations in Aft production are affected by antioxidants or, vice versa, whether oxidative stress is altered by inhibition of Aft;
Aim 3) Determine whether Aft is regulated by intracellular redox balance. Completion of the proposed studies will help determine the role of Aft and, more importantly, guide future therapeutic targets. ? ?
| Hou, Liming; Lee, Hyoung-Gon; Han, Fang et al. (2013) Modification of amyloid-?1-42 fibril structure by methionine-35 oxidation. J Alzheimers Dis 37:9-18 |
| Bonda, D J; Castellani, R J; Zhu, X et al. (2011) A novel perspective on tau in Alzheimer's disease. Curr Alzheimer Res 8:639-42 |
| Tabaton, Massimo; Zhu, Xiongwei; Perry, George et al. (2010) Signaling effect of amyloid-beta(42) on the processing of AbetaPP. Exp Neurol 221:18-25 |
| Valdez, Chris M; Smith, Mark A; Perry, George et al. (2010) Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers. Hippocampus 20:902-5 |
| Moreira, Paula I; Zhu, Xiongwei; Wang, Xinglong et al. (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212-20 |
| Bonda, David J; Mailankot, Maneesh; Stone, Jeremy G et al. (2010) Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. Redox Rep 15:161-8 |
| Mondragon-Rodriguez, Siddhartha; Basurto-Islas, Gustavo; Lee, Hyoung-gon et al. (2010) Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 10:683-91 |
| Gustaw-Rothenberg, Katarzyna A; Siedlak, Sandra L; Bonda, David J et al. (2010) Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Exp Gerontol 45:47-52 |
| Castellani, Rudy J; Rolston, Raj K; Smith, Mark A (2010) Alzheimer disease. Dis Mon 56:484-546 |
| Nunomura, Akihiko; Tamaoki, Toshio; Tanaka, Koich et al. (2010) Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis 37:731-7 |
Showing the most recent 10 out of 31 publications
